291 related articles for article (PubMed ID: 33686968)
1. A bioinformatic analysis: the overexpression and clinical significance of FCGBP in ovarian cancer.
Wang K; Guan C; Shang X; Ying X; Mei S; Zhu H; Xia L; Chai Z
Aging (Albany NY); 2021 Mar; 13(5):7416-7429. PubMed ID: 33686968
[TBL] [Abstract][Full Text] [Related]
2. [IgG Fc binding protein (FCGBP) as a prognostic marker of low-grade glioma and its correlation analysis with immune infiltration].
Liu Q; Zhang J; Zhang F; Zhang W; Gong L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Aug; 39(8):686-692. PubMed ID: 37515334
[TBL] [Abstract][Full Text] [Related]
3. Non-coding RNA-related FCGBP downregulation in head and neck squamous cell carcinoma: a novel biomarker for predicting paclitaxel resistance and immunosuppressive microenvironment.
Ding Q; Lin F; Huang Z; Li Y; Cai S; Chen X; Liu H; Qiu S
Sci Rep; 2024 Feb; 14(1):4426. PubMed ID: 38396056
[TBL] [Abstract][Full Text] [Related]
4. Fc fragment of IgG binding protein is correlated with immune infiltration levels in hepatocellular carcinoma.
Suo Y; Hou C; Yang G; Yuan H; Zhao L; Wang Y; Zhang N; Zhang X; Lu W
Biomol Biomed; 2023 Jul; 23(4):605-615. PubMed ID: 36803544
[TBL] [Abstract][Full Text] [Related]
5. FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma.
Shen T; Zhang J; Wang Y; Liu B
J Immunol Res; 2022; 2022():8443392. PubMed ID: 35733916
[TBL] [Abstract][Full Text] [Related]
6. IgG Fc Binding Protein (
Yuan Z; Zhao Z; Hu H; Zhu Y; Zhang W; Tang Q; Huang R; Gao F; Zou C; Wang G; Wang X
Onco Targets Ther; 2021; 14():967-977. PubMed ID: 33603401
[TBL] [Abstract][Full Text] [Related]
7. FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma.
Yan T; Tian D; Chen J; Tan Y; Cheng Y; Ye L; Deng G; Liu B; Yuan F; Zhang S; Cai L; Chen Q
Front Oncol; 2021; 11():769033. PubMed ID: 35047393
[TBL] [Abstract][Full Text] [Related]
8. Identification of three molecular subtypes based on immune infiltration in ovarian cancer and its prognostic value.
Liu J; Tan Z; He J; Jin T; Han Y; Hu L; Song J; Huang S
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33043974
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and immunological roles of Fc fragment of IgG binding protein in colorectal cancer.
Zhuang Q; Shen A; Liu L; Wu M; Shen Z; Liu H; Cheng Y; Lin X; Wu X; Lin W; Li J; Han Y; Chen X; Chen Q; Peng J
Oncol Lett; 2021 Jul; 22(1):526. PubMed ID: 34055091
[TBL] [Abstract][Full Text] [Related]
10. Multi-Omics Analyses to Identify FCGBP as a Potential Predictor in Head and Neck Squamous Cell Carcinoma.
Lin YH; Yang YF; Shiue YL
Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626334
[TBL] [Abstract][Full Text] [Related]
11. Clinical implication and immunological characterisation of the ARF-GEF family member CYTH4 in ovarian cancer.
Zhang Q; Wang Q; Wu S; Zhang J
Autoimmunity; 2020 Dec; 53(8):434-442. PubMed ID: 33078956
[TBL] [Abstract][Full Text] [Related]
12. HILPDA Is a Prognostic Biomarker and Correlates With Macrophage Infiltration in Pan-Cancer.
Liu C; Zhou X; Zeng H; Wu D; Liu L
Front Oncol; 2021; 11():597860. PubMed ID: 33816230
[No Abstract] [Full Text] [Related]
13. Different Forms of TFF3 in the Human Endocervix, including a Complex with IgG Fc Binding Protein (FCGBP), and Further Aspects of the Cervico-Vaginal Innate Immune Barrier.
Laskou A; Znalesniak EB; Harder S; Schlüter H; Jechorek D; Langer K; Strecker C; Matthes C; Tchaikovski SN; Hoffmann W
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396964
[TBL] [Abstract][Full Text] [Related]
14.
Zhao K; Yi Y; Ma Z; Zhang W
Front Genet; 2021; 12():705512. PubMed ID: 35058963
[No Abstract] [Full Text] [Related]
15. Role of the mucin-like glycoprotein FCGBP in mucosal immunity and cancer.
Liu Q; Niu X; Li Y; Zhang JR; Zhu SJ; Yang QY; Zhang W; Gong L
Front Immunol; 2022; 13():863317. PubMed ID: 35936008
[TBL] [Abstract][Full Text] [Related]
16. PTK7 protein is decreased in epithelial ovarian carcinomas with poor prognosis.
Wang H; Li G; Yin Y; Wang J; Wang H; Wei W; Guo Q; Ma H; Shi Q; Zhou X; Wang J
Int J Clin Exp Pathol; 2014; 7(11):7881-9. PubMed ID: 25550828
[TBL] [Abstract][Full Text] [Related]
17. M1 Polarization Markers Are Upregulated in Basal-Like Breast Cancer Molecular Subtype and Associated With Favorable Patient Outcome.
Hachim MY; Hachim IY; Talaat IM; Yakout NM; Hamoudi R
Front Immunol; 2020; 11():560074. PubMed ID: 33304345
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature.
Hinchcliff E; Paquette C; Roszik J; Kelting S; Stoler MH; Mok SC; Yeung TL; Zhang Q; Yates M; Peng W; Hwu P; Jazaeri A
Cancer Immunol Immunother; 2019 Sep; 68(9):1515-1526. PubMed ID: 31515669
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of KIF26B, Cell Migration and Proliferation of Human Ovarian Cancer Cell Lines In Vitro, and Patient Outcomes from Human Bioinformatic Analysis.
Yang X; Zhang L; Xie L
Med Sci Monit; 2018 Jun; 24():3863-3872. PubMed ID: 29880787
[TBL] [Abstract][Full Text] [Related]
20. A Novel Prognostic Marker and Therapeutic Target Associated with Glioma Progression in a Tumor Immune Microenvironment.
Zhang JJ; Zhang Y; Chen Q; Chen QN; Yang X; Zhu XL; Hao CY; Duan HB
J Inflamm Res; 2023; 16():895-916. PubMed ID: 36883185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]